PRF Technologies

PRFX

Drug Manufacturers - Specialty & Generic · Healthcare

Price

$1.15

-0.04 (-3.36%)

Market Cap

$92,612

Exchange

NASDAQ Capital Market

Winston Score

Winston is worried

Weak fundamentals across most pillars.

Share count rising — dilution

+39531.4% over 4y

The company has issued more shares over this period, which dilutes each existing shareholder’s stake.

Diluted shares outstanding: 2K (2021) → 648K (2025)

PRF Technologies Ltd. is a small specialty pharmaceutical company focused on developing drug delivery technologies and formulations. It works on creating improved versions of existing medicines, aiming to make drugs easier to use or more effective. Its target customers are typically healthcare providers, hospitals, and pharmaceutical partners who license or purchase its formulations.

The company earns money primarily through licensing agreements, research partnerships, and eventually product sales once drugs reach the market. Its deeply negative gross and operating margins show it is still in an early development stage, spending heavily on research while generating little revenue. The main risk is that it must successfully advance its pipeline through clinical trials and regulatory approvals before running out of cash, which is a common and serious challenge for small pre-revenue pharmaceutical companies.

Winston Score History

Growth Profile

For growth stock investors

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

Revenue data limited

EPS Growth

+90.3% YoY

YoY Growth Rate

EPS growth accelerating

R&D Spend

$1M/ year

↓ Declining (-90% vs prior year)

>1,000% of revenue

371.2x the sector average (18%)

R&D spend declining — could signal cost-cutting or efficiency

Insider Activity

4.6%ownership

Relatively low insider ownership

Cash Runway

~13 months

$4M cash & investments

Quarterly Free Cash Flow

→ Burn rate stable

Adequate runway but may need to raise capital within 2 years

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Gross Margin

-311.8%

Thin — -311.8% gross margin

Operating Margin

-16200.0%

Losing money on operations — -16200.0%

ROCE

-16.1%

Weak — -16.1% return on capital

Negative ROIC means the business is losing money on every dollar invested in it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales YoY

+166659512925690.1%

Fast-growing sales (166659512925690.1% YoY)

EPS YoY

N/A

Data not available

EPS Consistency

0/8 quarters

Earnings rarely grow — volatile business

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Cash Conversion

N/A

—

Data not available

FCF Margin

-23276.5%

Burning cash (-23276.5%)

Free cash flow is negative. They are burning cash, not generating it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

Debt / Equity

N/A

Data not available

Interest Cover

N/A

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

P/E Ratio (TTM)

N/M

—

Negative earnings — P/E not meaningful

P/E vs Forward

N/A

not available

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.

🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.

Start free trial